Article metrics

Download PDFPDF

Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials

 

Online download statistics by month:

Online download statistics by month: September 2018 to October 2022

AbstractFullPdf
Sep 201824725536
Oct 201812081396309
Nov 2018756851192
Dec 2018573668123
Jan 201924834786
Feb 201915421938
Mar 201918121976
Apr 201912111930
May 201914213851
Jun 201911210945
Jul 201915215339
Aug 201912612433
Sep 201911511417
Oct 201915214941
Nov 201914213640
Dec 201913813866
Jan 202014713956
Feb 202011711440
Mar 202011010332
Apr 20201029421
May 202010110056
Jun 2020848030
Jul 202021020746
Aug 202063663045
Sep 2020949034
Oct 202010910261
Nov 2020747560
Dec 2020837632
Jan 2021968250
Feb 2021685744
Mar 2021787457
Apr 2021585533
May 202111210160
Jun 2021888344
Jul 2021787345
Aug 2021817930
Sep 20211069950
Oct 2021827849
Nov 2021716938
Dec 2021586033
Jan 2022565326
Feb 2022626222
Mar 2022767138
Apr 202211111937
May 202212512037
Jun 2022797339
Jul 2022827623
Aug 202210610243
Sep 2022949136
Oct 2022917924
Total829287012593